Ewing's sarcoma

Active Research Protocols

  1. 00-C-0092 – A Randomized Trial of Filgrastim-SD/01 vs. Filgrastim in Newly Diagnosed Children and Young Adults with Sarcoma Treated with Dose-Intensive Chemotherapy
  2. 01-C-0091 – Phase I Trial and Pharmacokinetic Study of Tariquidar (XR9576), a P-Glycoprotein Inhibitor, in Combination with Doxorubicin, Vinorelbine or Docetaxel in Pediatric Patients with Refractory Solid Tumors Including Brain Tumors
  3. 02-C-0259 – Pilot Study of Allogeneic/Syngeneic Blood Stem Cell Transplantation in Patients with High-Risk and Recurrent Pediatric Sarcomas
  4. 07-C-0040 – A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors
  5. 07-C-0206 – A Pilot Study of Tumor Vaccination and R-hIL-7 Following Standard Multimodality Therapy in Patients with High Risk Pediatric Solid Tumors
  6. 08-C-0080 – SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas
  7. 09-C-0054 – A Group Wide Biology and Banking Study for Phase II Study of R1507
  8. 11-C-0073 – A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation from Related or Matched Unrelated Donors in Pediatric Patients with Solid Tumors and Leukemias
  9. 12-C-0135 – Phase I/II Trial of Mithramycin in Children and Adults with Refractory Extracranial Solid Tumors (Phase I) or Ewing Sarcoma and EWSFLI1 Fusion Transcript (Phase II)
  10. 97-C-0050 – A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 with or without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas
  11. 97-C-0052 – A Pilot Study of Autologous T-Cell Transplantation with Vaccine Driven Expansion of Anti-Tumor Effectors after Cytoreductive Therapy in Metastatic Pediatric Sarcomas
  12. 98-C-0037 – Treatment of Children with Cancer
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014